Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Hims & Hers Health, Inc. Class A Common Stock
(NY:
HIMS
)
39.20
-0.82 (-2.05%)
Official Closing Price
Updated: 7:00 PM EST, Dec 5, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Hims & Hers Health, Inc. Class A Common Stock
< Previous
1
2
...
23
24
25
26
27
28
29
30
31
...
48
49
Next >
Why Hims & Hers Health Stock Is Plummeting Today
↗
February 21, 2025
Via
The Motley Fool
Top movers in Friday's session
↗
February 21, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
Stocks Firmly Lower As Consumer Sentiment Weakens
↗
February 21, 2025
The Dow Jones Industrial Average is headed for another sharp triple-digit drop to end the week.
Via
Talk Markets
Topics
Stocks
Stocks / Equities
What's Going On With Hims & Hers Health Stock Today?
↗
February 21, 2025
Hims & Hers Health acquired a peptide facility to strengthen its U.S. supply chain and meet demand for personalized treatments. Also, in another development, FDA resolves semaglutide injection...
Via
Benzinga
Topics
Economy
Why Novo Nordisk Stock Popped on Friday
↗
February 21, 2025
Via
The Motley Fool
Why the growth investor may take a look at NYSE:HIMS.
↗
February 21, 2025
A fundamental analysis of (NYSE:HIMS): HIMS & HERS HEALTH INC (NYSE:HIMS) showing high EPS and FCF growth while beating expectations
Via
Chartmill
Why Hims & Hers Stock Dropped Today
↗
February 20, 2025
Via
The Motley Fool
Market Whales and Their Recent Bets on HIMS Options
↗
February 20, 2025
Via
Benzinga
Hims Stock Crashes After FDA Resolves Weight-Loss Drugs Shortage
↗
February 21, 2025
The FDA said the shortages in Novo Nordisk's weight-loss drug has been resolved.
Via
Investor's Business Daily
Hims & Hers Acquires US-based Peptide Facility
February 21, 2025
From
Hims & Hers
Via
Business Wire
Buy HIMS Stock Here
↗
February 19, 2025
In this video, I provide my technical analysis for how I would manage the risk and book the profits on the trade.
Via
Talk Markets
Topics
Stocks / Equities
Hims & Hers Hits New Highs On At-Home Lab Testing Plans: Retail Sees More Room To Run, Analysts Divided
↗
February 19, 2025
One analyst warned that elevated growth expectations could lead to near-term volatility as the company introduces its FY25 guidance.
Via
Stocktwits
Why Hims & Hers Health Stock Is Skyrocketing Today
↗
February 19, 2025
Via
The Motley Fool
What Is Driving Hims & Hers Stock Higher?
↗
February 18, 2025
The stock is up 140% this year already.
Via
The Motley Fool
Assessing Hims & Hers Health: Insights From 7 Financial Analysts
↗
February 18, 2025
Via
Benzinga
Why Is Hims & Hers Health (HIMS) Stock Rocketing Higher Today
February 19, 2025
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 24.8% in the afternoon session after the company announced the acquisition of Sigmund (marketed as Trybe Labs), which will allow it to...
Via
StockStory
Topics
Artificial Intelligence
Digesting Super Bowl Ads, Dunkin' & Starbucks Plans, and Some Weight Loss Drug News
↗
February 19, 2025
The big game didn't live up to the big billing, but there was plenty to take in during commercial breaks and halftime.
Via
The Motley Fool
Garmin Posts Better-Than-Expected Results, Joins SolarEdge Technologies, Compass, Appian And Other Big Stocks Moving Higher On Wednesday
↗
February 19, 2025
Via
Benzinga
Hims & Hers Health Stock Hits All-Time Highs: What's Going On?
↗
February 19, 2025
Hims & Hers Health Inc (NYSE:HIMS) shares are soaring Wednesday after the company announced plans to introduce at-home lab testing. Positive analyst coverage may also be boosting the stock. Here's what...
Via
Benzinga
Hims & Hers Acquires At-Home Lab Testing Facility, Expanding Capabilities to Ultimately Include Affordable Whole Body Testing for Subscribers
February 19, 2025
From
Hims & Hers
Via
Business Wire
Hims & Hers Earnings Could Be a Game Changer—What to Do Now
February 18, 2025
After a massive 500% run over the past 12 months, shares of Hims & Hers stock might have another trick saved up before earnings announcements.
Via
MarketBeat
3 Hot Stocks That Have Already Doubled in 2025
↗
February 18, 2025
It may be early, but some blazing investments have already delivered wealth-altering gains in this young year.
Via
The Motley Fool
Hims & Hers Stock Is On Fire, But Is It a Bubble?
↗
February 18, 2025
The stock isn't as expensive as you might think.
Via
The Motley Fool
This Moderna Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
↗
February 18, 2025
Via
Benzinga
Coinbase To Rally Over 11%? Here Are 10 Top Analyst Forecasts For Tuesday
↗
February 18, 2025
Via
Benzinga
Hims & Hers: From Viral Ad to Volatile Stock
February 18, 2025
Hims & Hers leverages its viral Super Bowl advertisement and strategic weight loss market entry to achieve stock gains and brand recognition in telehealth.
Via
MarketBeat
Hims & Hers Health Stock: A Millionaire-Maker in the Making?
↗
February 18, 2025
The stock has sprinted past $50 per share, after trading at $3 less than two years ago.
Via
The Motley Fool
Hims & Hers Stock: More Gains Ahead Or A Pullback? Most Retail Traders Bet On This Path
↗
February 18, 2025
A poll of over 4,000 respondents found that 47% believe the stock will continue its climb past $60, while 44% expect a significant pullback for profit-taking.
Via
Stocktwits
Novo Nordisk Shares Near New 52-Week Low: Analysts See Big Upside
February 17, 2025
Novo Nordisk shares are closing in on a new 52-week low. Is the stock gearing up for a recovery with sentiment currently low?
Via
MarketBeat
Super Micro Computer, Intel, Alibaba And CVS Are Among Top 13 Large-Cap Gainers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio?
↗
February 16, 2025
In the last week, these 13 large-cap stocks were top performers. Are they in your portfolio? HIMS, AUR, APP, SMCI, TEM, DKNG, INTC, MNDY, BROS, CVS, BABA, AAPL, ABNB.
Via
Benzinga
< Previous
1
2
...
23
24
25
26
27
28
29
30
31
...
48
49
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
